Vice President, Life Science
COTA- Full Time
- Senior (5 to 8 years)
Employment Type: Full time Location Type: [Not Specified] Salary: [Not Specified]
Tempus is seeking an experienced and strategic Area Vice President (AVP) to lead and grow one of our key regional teams within the Life Sciences division. This role involves overseeing strategic engagement with top Pharma and Biotech organizations. Reporting directly to the Senior Vice President, Sales, Life Sciences, the AVP is responsible for leading a regional team of Key Account Directors (KADs), driving regional sales strategy, ensuring achievement of revenue targets, and fostering deep strategic relationships with biopharma clients. The AVP is critical in aligning internal teams and resources to maximize regional growth and client satisfaction.
Tempus is a technology company focused on precision medicine. We connect an entire ecosystem of real-world evidence to deliver real-time, actionable insights to physicians, providing critical information about the right treatments for the right patients, at the right time. Our proprietary platform leverages advancements in AI to impact clinical care meaningfully.
AI-driven healthcare data analysis platform
Tempus focuses on enhancing patient outcomes through the use of data and artificial intelligence in healthcare. The company offers a platform that analyzes medical data to provide insights for physicians, helping them make better treatment decisions. This platform also aids pharmaceutical and biotech companies in drug development by identifying new targets and assessing treatment effectiveness. For patients, Tempus identifies personalized therapy options, particularly in cancer care, where their research has shown increased opportunities for tailored treatments. They have developed a pan-cancer organoid platform and a liquid biopsy assay for profiling circulating tumor DNA. Tempus generates revenue by charging healthcare providers and companies for access to their platform and insights, setting them apart from competitors by their focus on personalized medicine and extensive cancer research.